![]() |
市场调查报告书
商品编码
1776767
2032 年远端患者监护市场预测:按产品、传输、交付模式、技术、应用、最终用户和地区进行的全球分析Remote Patient Monitoring Market Forecasts to 2032 - Global Analysis By Offering (Devices, Software, Services and Other Offerings), Transmission (Synchronous and Asynchronous), Mode of Delivery, Technology, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球远端患者监护市场预计在 2025 年达到 316 亿美元,到 2032 年将达到 802 亿美元,预测期内的复合年增长率为 14.2%。
远端患者监护(RPM) 是一种利用数位技术在传统临床环境之外收集病患医疗资料的医疗保健技术。穿戴式装置、智慧感测器和行动应用程式等装置可以追踪生命征象、慢性病和治疗进度。这些数据会安全地传递给医疗服务提供者,以便持续监测和及时介入。 RPM 可以改善患者的治疗效果,减少就诊次数,并支持主动护理,特别适用于长期患病或居家復健的患者。
梅奥诊所 COVID-19远端患者监护计画的回顾性分析发现,使用 RPM 的病患的 30 天死亡率为 0.5%,而未使用 RPM 的病患为 1.7%,住院率和 ICU 入院率也明显较低。
慢性病负担加重和人口老化
随着人口老化,医疗保健系统面临更有效地管理长期疾病的压力。远端患者监护提供了一种扩充性的解决方案,可以即时追踪家中的生命体征,减少住院次数,并改善护理协调。穿戴式科技与行动医疗平台的整合进一步提高了医疗服务的可近性和病人参与。向主动照护的转变正在改变传统的医疗保健服务模式。
缺乏患者数位素养和技术采用
老年患者以及居住在农村或医疗资源匮乏地区的患者在使用连网设备和远端医疗平台时往往面临挑战。这种数位落差可能会阻碍远距医疗计画(RPM)的有效性,并导致现有工具的利用不足。此外,对资料隐私和设备可用性的担忧也加剧了患者的犹豫。弥合这一差距需要有针对性的教育、简化的介面以及全面的设计策略。
拓展新的治疗领域与应用
远端监控已不再局限于慢性病管理,而是扩展到术后护理、心理健康和感染疾病监测。生物感测器和人工智慧主导分析领域的创新,使远端监控解决方案能够支援更广泛的临床场景。例如,在非医院环境中持续监测神经系统参数和復健进展也变得可行。这种多样化正在为设备製造商和服务供应商带来新的收益来源,同时改善各专科患者的治疗效果。
临床医生的数据过载和警报疲劳
频繁的警报,尤其是误报,可能会导致患者对警报的敏感度降低、响应延迟或错过关键事件。这种现象称为警报疲劳,它会降低监测系统的可靠性,并增加不良后果的风险。为了缓解这种情况,开发人员正在转向智慧演算法,对可操作的警报进行优先排序,并将患者资料与具体情况相结合。然而,如何在自动化与临床判断之间取得平衡仍然是一项复杂的挑战。
疫情催生了远距医疗管理 (RPM) 的采用,凸显了其在减少面对面护理和保护弱势群体方面的作用。虽然初期供应链中断影响了设备可得性,远端医疗远端系统管理慢性病以及支持紧张的医疗保健系统至关重要。
预计设备部分将成为预测期内最大的部分
由于设备在收集患者资料方面发挥重要作用,预计在预测期内将占据最大的市场占有率。从穿戴式感测器到可植入式监视器,这些工具能够持续洞察生理参数。它们在医院、居家医疗和门诊环境中的广泛应用证明了其多功能性。製造商正在投资小型化、电池效率和互通性,以提升设备性能和用户舒适度。
预测期内,联网/无线监控领域预计将以最高复合年增长率成长
预计在预测期内,互联/无线监控领域将实现最高成长率,这得益于物联网医疗设备和行动连线的普及。这些解决方案能够将资料无缝传输到云端平台,从而实现即时分析和远端介入。无线系统的便利性,尤其是在家庭环境中,正在加速病患对医疗服务提供者的接受和采用。
北美预计将在预测期内占据最大市场占有率,这得益于其强大的医疗基础设施和较高的慢性病盛行率。该地区受益于优惠的报销政策、强劲的数位医疗普及率以及对远距医疗 (RPM) 技术的积极投资。美国和加拿大的领先公司正在透过战略合作伙伴关係和产品发布推动技术创新。此外,消费者对居家照护的认知和需求正在加强远距医疗在主流医疗保健服务中的作用。
预计北美将在预测期内实现最高的复合年增长率,原因如下:该地区对基于价值的医疗服务的重视,加上对远端医疗的监管支持,正在加速远距医疗平台 (RPM) 的整合。人工智慧、云端运算和穿戴式技术的进步进一步推动了市场扩张。随着医疗服务提供者寻求可扩展的人口健康管理解决方案,RPM 正成为该地区数位转型的关键。
According to Stratistics MRC, the Global Remote Patient Monitoring Market is accounted for $31.6 billion in 2025 and is expected to reach $80.2 billion by 2032 growing at a CAGR of 14.2% during the forecast period. Remote Patient Monitoring (RPM) is a healthcare practice that uses digital technologies to collect medical data from patients outside of traditional clinical settings. Devices such as wearables, smart sensors, and mobile apps track vital signs, chronic conditions, or treatment progress. This data is securely transmitted to healthcare providers for continuous monitoring and timely intervention. RPM improves patient outcomes, reduces hospital visits, and supports proactive care particularly for individuals managing long-term illnesses or recovering from procedures in home-based environments.
According to a retrospective analysis of Mayo Clinic's COVID-19 remote patient monitoring program, engaged patients had a 30-day mortality rate of 0.5% compared to 1.7% for non engaged patients, and showed significantly lower rates of hospitalization and ICU admission.
Rising burden of chronic diseases and aging population
As populations age, healthcare systems are under pressure to manage long-term illnesses more efficiently. Remote patient monitoring offers a scalable solution by enabling real-time tracking of vital signs from home, reducing hospital admissions and improving care coordination. The integration of wearable technologies and mobile health platforms further enhances accessibility and patient engagement. This shift toward proactive care is transforming traditional healthcare delivery models.
Lack of digital literacy and technological adoption among patients
Elderly patients and those in rural or underserved areas often face challenges in using connected devices or navigating telehealth platforms. This digital divide hampers the effectiveness of RPM programs and may lead to underutilization of available tools. Additionally, concerns around data privacy and device usability contribute to hesitation among patients. Bridging this gap requires targeted education, simplified interfaces, and inclusive design strategies.
Expansion into new therapeutic areas and applications
Remote monitoring is no longer confined to chronic disease management it's expanding into post-operative care, mental health, and infectious disease surveillance. Innovations in biosensors and AI-driven analytics are enabling RPM solutions to support a broader range of clinical scenarios. For example, continuous monitoring of neurological parameters or rehabilitation progress is becoming feasible outside hospital settings. This diversification opens new revenue streams for device manufacturers and service providers, while also enhancing patient outcomes across specialties.
Data overload and alert fatigue for clinicians
Frequent alerts especially false positives can lead to desensitization, delayed responses, or missed critical events. This phenomenon, known as alert fatigue, undermines the reliability of monitoring systems and increases the risk of adverse outcomes. To mitigate this, developers are focusing on intelligent algorithms that prioritize actionable alerts and contextualize patient data. However, balancing automation with clinical judgment remains a complex task.
The pandemic acted as a catalyst for RPM adoption, highlighting its role in minimizing in-person visits and safeguarding vulnerable populations. While initial supply chain disruptions affected device availability, the surge in telehealth usage and remote consultations drove long-term growth. RPM became essential for monitoring COVID-positive patients at home, managing chronic conditions remotely, and supporting overwhelmed healthcare systems.
The devices segment is expected to be the largest during the forecast period
The devices segment is expected to account for the largest market share during the forecast period due to its foundational role in capturing patient data. From wearable sensors to implantable monitors, these tools provide continuous insights into physiological parameters. Their widespread adoption across hospitals, home care, and ambulatory settings underscores their versatility. Manufacturers are investing in miniaturization, battery efficiency, and interoperability to enhance device performance and user comfort.
The connected / wireless monitoring segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the connected / wireless monitoring segment is predicted to witness the highest growth rate driven by the proliferation of IoT-enabled health devices and mobile connectivity. These solutions allow seamless data transmission to cloud platforms, enabling real-time analytics and remote interventions. The convenience of wireless systems especially in home settings has accelerated patient acceptance and provider adoption.
During the forecast period, the North America region is expected to hold the largest market share attributed to robust healthcare infrastructure and high chronic disease prevalence. The region benefits from favorable reimbursement policies, strong digital health adoption, and active investment in RPM technologies. Leading players in the U.S. and Canada are driving innovation through strategic collaborations and product launches. Additionally, consumer awareness and demand for home-based care are reinforcing RPM's role in mainstream healthcare delivery.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR owing to The region's emphasis on value-based care, coupled with regulatory support for telehealth, is accelerating RPM integration. Advances in AI, cloud computing, and wearable tech are further propelling market expansion. As healthcare providers seek scalable solutions for population health management, RPM is emerging as a cornerstone of digital transformation in the region.
Key players in the market
Some of the key players in Remote Patient Monitoring Market include Welch Allyn, Vivify Health, Tunstall Healthcare, ResMed Inc., Qardio Inc., Philips Healthcare, Medtronic plc, Masimo Corporation, iRhythm Technologies, Honeywell Life Care Solutions, Health Recovery Solutions, GE HealthCare, Care Innovations, Boston Scientific Corporation, BioTelemetry, AMC Health, AliveCor Inc and Abbott Laboratories
In June 2025, Medtronic announced "MiniMed" as the official name for its upcoming spin-off, the new standalone diabetes care business. This rebranding honors legacy origins and positions the company for focused growth and innovation in diabetes management.
In May 2025, AliveCor launched its flagship AI-powered KardiaMobile 6L Max and introduced KardiaAlert, an advanced ECG monitoring feature for subscribers. This marks its most sophisticated personal ECG system, integrating six-lead AI detection to improve heart rhythm alerts.
In March 2024, Boston Scientific agreed to acquire SoniVie Ltd., a developer of TIVUS(TM) intravascular ultrasound systems for renal denervation. The acquisition enhances the company's interventional cardiology portfolio with novel hypertension treatment devices.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.